What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians

被引：3
|
作者：
Massie, BM [1 ]
机构：
[1] Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2002年 / 8卷 / 04期
关键词：
D O I：
10.1054/jcaf.2002.127612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：197 / 201
页数：5
相关论文
共 50 条
  • [21] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The losartan intervention for endpoint reduction in hypertension (LIFE) Trial - Letter regarding article by Devereux et al.
    O'Rourke, MF
    Safar, ME
    CIRCULATION, 2005, 111 (22) : E377 - E377
  • [22] An analysis of cholesterol control and statin use in the Losartan intervention for Endpoint reduction in hypertension study
    Kristianson, K
    Fyhrquist, F
    Devereux, RB
    Kjeldsen, SE
    Lindholm, LH
    Lyle, PA
    Nieminen, MS
    Snapinn, SM
    CLINICAL THERAPEUTICS, 2003, 25 (04) : 1186 - 1199
  • [23] Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy
    Kjeldsen, SE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Aurup, P
    Edelman, J
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Snapinn, S
    Wedel, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (12): : 1491 - 1498
  • [24] Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
    Olsen, Michael Hecht
    Wachtell, Kristian
    Beevers, Gareth
    Dahlof, Bjorn
    de Simone, Giovanni
    Devereux, Richard B.
    de Faire, Ulf
    Fyhrquist, Frej
    Ibsen, Hans
    Kjeldsen, Sverre E.
    Lederballe-Pedersen, Ole
    Lindholm, Lars H.
    Lyle, Paulette A.
    Nieminen, Markku S.
    Omvik, Per
    Oparil, Suzanne
    Wedel, Hans
    JOURNAL OF HYPERTENSION, 2009, 27 (03) : 567 - 574
  • [25] Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
    Lindholm, LH
    Ibsen, H
    Borch-Johnsen, K
    Olsen, MH
    Wachtell, K
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristianson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Aurup, P
    Edelman, JM
    Snapinn, S
    JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1879 - 1886
  • [26] Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol -: The Losartan Intervention for Endpoint reduction in hypertension study
    Kizer, JR
    Dahlöf, B
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Wachtell, K
    Edelman, JM
    Snapinn, SM
    Harris, KE
    Devereux, RB
    HYPERTENSION, 2005, 45 (01) : 46 - 52
  • [27] Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients -: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
    Okin, PM
    Jern, S
    Devereux, RB
    Kjeldsen, SE
    Dahlöf, B
    HYPERTENSION, 2000, 35 (01) : 13 - 18
  • [28] Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension -: A losartan intervention for endpoint-reduction in hypertension (LIFE) substudy
    Olsen, MH
    Wachtell, K
    Bella, JN
    Palmieri, V
    Gerdts, E
    Smith, G
    Nieminen, MS
    Dahlöf, B
    Ibsen, H
    Devereux, RB
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (11) : 1430 - 1436
  • [29] QRS duration predicts sudden cardiac death in hypertensive patients:: The losartan intervention for endpoint reduction in hypertension (LIFE) study
    Morin, Daniel P.
    Olkarinen, Lasse
    Viltasalo, Matti
    Tolvonen, Lauh
    Nieminen, Markku S.
    Keldsen, Sverre E.
    Dahloef, Bjorn
    Devereux, Richard B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 21A - 21A
  • [30] Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wan, Y
    HYPERTENSION, 2005, 45 (02) : 198 - 202
12345